Browse Category

NYSE:RELX.N News 17 January 2026

RELX share price: what to watch after Friday’s dip and a fresh buyback filing

RELX share price: what to watch after Friday’s dip and a fresh buyback filing

London, Jan 17, 2026, 08:00 GMT — The market has closed. RELX (REL.L) ended the week on a down note, slipping 0.93% to 3,094 pence Friday. The stock fluctuated between 3,070 and 3,122 pence, with roughly 6.9 million shares changing hands. (Investing) London’s mood stayed subdued. The FTSE 100 dipped 0.04% to 10,235.29, pulling back from a record close the…

Stock Market Today

  • Johnson & Johnson and Merck: Two Healthcare Stocks to Hold for 20 Years
    January 23, 2026, 1:21 PM EST. Johnson & Johnson (JNJ) and Merck (MRK) stand out as durable picks for long-term investors, driven by strong healthcare franchises. Merck's oncology focus, led by its blockbuster cancer drug Keytruda, positions it for continued sales growth despite looming patent expiration in 2028. The company also expands with new approvals and formulations to sustain momentum. Johnson & Johnson benefits from a diversified portfolio across pharmaceuticals and medical devices, consistently delivering revenue and earnings, even amid challenges. Both stocks offer attractive dividend yields - Merck at 3.1% with nearly doubling payouts historically, and Johnson & Johnson at 2.35%. Their scale, innovation, and dividend track records make them solid candidates for wealth accumulation over two decades, despite short-term volatility.
Go toTop